Avantor Investor Conference Presentation Deck

Diversified portfolio provides resilient revenue profile¹ Equipment & Instrumentation Services & Specialty Procurement OFFERING 15% 15% ~50% Proprietary 30% Proprietary Materials & Consumables Navantor™ Third-Party Materials & Consumables 40% 1. FY20 estimate Education & Government Advanced Technologies & Applied Materials END MARKETS Healthcare 15% 25% 10% ~70% Life Sciences 15% Production 35% R&D Biopharma ~85% RECURRING REVENUE Europe 35% GEOGRAPHY AMEA 5% ~180 Countries 60% Americas 39th Annual J.P. Morgan Healthcare Conference 8

View entire presentation